Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bispecific Antibodies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06529718
What this trial is testing

Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients

Who this might be right for
Biliary Tract Cancer
UNICANCER 72
Testing effectiveness (Phase 2)Looking for participantsNCT06996132
What this trial is testing

Bispecific Antibody-Based Salvage Therapy Followed by CAR-T ± ASCT in R/R Aggressive B-Cell Lymphoma

Who this might be right for
Relapsed or Refractory Aggressive B-cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 25
Testing effectiveness (Phase 2)Looking for participantsNCT05523947
What this trial is testing

Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor

Who this might be right for
HER2-Positive Solid Tumor
Yuhan Corporation 147
Post-approval studies (Phase 4)Not Yet RecruitingNCT07554014
What this trial is testing

A Single-center, Prospective, Self-controlled, Observational Real-world Study of the Efficacy and Safety of Anti-IL-17A/F Monoclonal Antibody Combined With Non-ablative Dot Laser for the Treatment of Mild to Moderate Hidradenitis Suppurativa

Who this might be right for
Hidradenitis Suppurativa (HS)
Second Affiliated Hospital, Zhejiang University, School of Medicine 50
Early research (Phase 1)Active Not RecruitingNCT03399799
What this trial is testing

Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Hematological Malignancies
Janssen Research & Development, LLC 279
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07029776
What this trial is testing

MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)
University of Arkansas 50
Testing effectiveness (Phase 2)Looking for participantsNCT05882370
What this trial is testing

TIPS Plus Cadonilimab in Advanced HCC with Tumor Thrombosis-associated Portal Hypertension:a Prospective, Single-arm, Phase II Study

Who this might be right for
Hepatocellular Carcinoma
Fei Gao 30
Testing effectiveness (Phase 2)Looking for participantsNCT07079631
What this trial is testing

A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
BioNTech SE 482
Testing effectiveness (Phase 2)Active Not RecruitingNCT05775159
What this trial is testing

Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer

Who this might be right for
Hepatocellular CarcinomaBiliary Tract Cancer
AstraZeneca 294
Early research (Phase 1)Study completedNCT04501770
What this trial is testing

M802 (HER2 and CD3) in HER2-Positive Advanced Solid Tumors

Who this might be right for
HER2-Positive Solid Tumors
Wuhan YZY Biopharma Co., Ltd. 34
Not applicableWithdrawnNCT06769555
What this trial is testing

BCMA/CD3 BiTE for RRAL or NDAL Amyloidosis With Insufficient Depth of Hematologic Response After Induction Therapy

Who this might be right for
AL Amyloidosis
Institute of Hematology & Blood Diseases Hospital, China
Testing effectiveness (Phase 2)Ended earlyNCT03983395
What this trial is testing

Study of ISB 1302 (CD3 Bispecific Ab) in HER2-positive Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Ichnos Sciences SA 1
Testing effectiveness (Phase 2)Study completedNCT05773105
What this trial is testing

Cadonilimab Combined With Regorafenib in Patients With Advanced HCC

Who this might be right for
Advanced Hepatocellular Carcinoma
Sun Yat-sen University 36
Testing effectiveness (Phase 2)Study completedNCT01221675
What this trial is testing

TF2- Small Cell Lung Cancer Radio Immunotherapy

Who this might be right for
Small Cell Lung CancerCEA-expressing Non Small Cell Lung Carcinoma (NSCLC)
Centre René Gauducheau 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06586294
What this trial is testing

Anti-PD-1 and LAG-3 Bispecific Antibody(AK129) Combined With Chemotherapy With or Without Cadonilimab in the First-line Treatment of Unresectable Locally Advanced or Metastatic G/ GEJ Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Akeso 294
Testing effectiveness (Phase 2)UnknownNCT05930665
What this trial is testing

Study of Cadonilimab Combined With Bevacizumab and Standard Chemotherapy as First Line Therapy in Unresectable Pleural Mesothelioma

Who this might be right for
Pleural Mesothelioma
Sun Yat-sen University 38
Testing effectiveness (Phase 2)Looking for participantsNCT07255404
What this trial is testing

A Clinical Trial Testing the Safety of Pumitamig (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
BioNTech SE 105
Large-scale testing (Phase 3)Active Not RecruitingNCT06230224
What this trial is testing

A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma

Who this might be right for
B-Cell Non-Hodgkin Lymphoma (B-NHL)
Regeneron Pharmaceuticals 216
Testing effectiveness (Phase 2)Looking for participantsNCT07432022
What this trial is testing

A Phase I/II Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of the EMB-07 Combination Therapy in Patients With Aggressive B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Combination TherapyAggressive B-Cell Non-Hodgkin LymphomaEMB07+1 more
Shanghai EpimAb Biotherapeutics Co., Ltd. 115
Early research (Phase 1)Looking for participantsNCT06166888
What this trial is testing

AK131 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Akeso 130
Next Page